Projecting lifetime HIV-related healthcare costs for youth with HIV in the United States.

ABSTRACT:

Background and objectives

US youth with HIV (YHIV) face challenges to antiretroviral therapy (ART) adherence and care engagement. Understanding YHIV healthcare costs is essential for healthcare payers and for evaluating the cost-effectiveness of youth-focused interventions.

Methods

Using the CEPAC-Adolescent microsimulation model, we simulated YHIV cohorts, including those with HIV acquired perinatally (15%) and non-perinatally (85%), aged 13-24 years, in care and prescribed ART. We projected undiscounted life expectancy from model start; per-person and population-level (n = 24,626) lifetime HIV-related healthcare costs (discounted at 3% annually) from a health payer perspective.

Results

YHIV were projected to live 47.4 life-years after model start, with discounted li

SUBMITTER: Jones ML 

PROVIDER: S-EPMC12797550 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature